rs370004832
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_153704.6(TMEM67):c.2009C>T(p.Thr670Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000129 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T670T) has been classified as Benign.
Frequency
Consequence
NM_153704.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM67 | NM_153704.6 | c.2009C>T | p.Thr670Ile | missense_variant | 20/28 | ENST00000453321.8 | NP_714915.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM67 | ENST00000453321.8 | c.2009C>T | p.Thr670Ile | missense_variant | 20/28 | 1 | NM_153704.6 | ENSP00000389998.3 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251388Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135868
GnomAD4 exome AF: 0.000126 AC: 184AN: 1461730Hom.: 0 Cov.: 31 AF XY: 0.000153 AC XY: 111AN XY: 727178
GnomAD4 genome AF: 0.000164 AC: 25AN: 152290Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74474
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 10, 2016 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in the heterozygous state in a patient with features of a severe nephronophthisis associated ciliopathy in published literature (Otto et al., 2011); This variant is associated with the following publications: (PMID: 21068128) - |
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2022 | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 670 of the TMEM67 protein (p.Thr670Ile). This variant is present in population databases (rs370004832, gnomAD 0.09%). This missense change has been observed in individual(s) with Senior-Loken syndrome (PMID: 21068128). ClinVar contains an entry for this variant (Variation ID: 497917). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TMEM67 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Meckel syndrome, type 3;C1853153:Joubert syndrome 6;C1865794:RHYNS syndrome;C2673874:Bardet-Biedl syndrome 14;C3150796:Nephronophthisis 11;C5435651:COACH syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 13, 2024 | - - |
COACH syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 16, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
TMEM67-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 12, 2024 | The TMEM67 c.2009C>T variant is predicted to result in the amino acid substitution p.Thr670Ile. This variant has been reported in an individual with Senior-Loken syndrome (Otto et al. 2010. PubMed ID: 21068128). This variant is reported in 0.078% of alleles in individuals of South Asian descent in gnomAD, which may be too common to be causative. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at